Q2 Results On Oct 26, 2016 (Board Meeting)

You might also like

Download as pdf or txt
Download as pdf or txt
You are on page 1of 1

@

ainntnpharmalimited

Ajanta House,
Mumbai 400 067
lndia

14th

+91 22 6606 1000

www.ajantaPharma.com

P +91 226606L200
E info@ajantaPharma.com

Charkop, Kandivli West,

October,2016

BSE LIMITED

Phiroze Jeejeebhoy Towers


Dalat Street,
Mumbai - 400 001

National Stock Exchange of India,


Exchange Ptaza, 5th Floor, Plot no. Cl1, G Btock,
Bandra Kurta Complex, Bandra (East),
Mumbai - 400 051

Scrip Code: BSE - AJANTPHARM 532331/ NSE - AJANTPHAR

EQ

Re: Compliance pursuant to Regulation 29 - Notice of Board Meeting

Dear Sir/Madam,

Pursuant to Regutation 29 of the Listing Regutations, we hereby inform that a Meeting of


the Board of Directors of the Company witt be hetd on Wednesday, 26th October, 2016 at

the Registered Office of the Company at "Ajanta House", Charkop, Kandivti


Mumbai - 400 067, to consider inter atia :

1.

Approving and taking on record Unaudited (Consotidated

2.

Resutts of
September,2016.
Dectaration of interim dividend for financiat year 7016-17.

(West),

& Standalone) Financiat


quarter
and hatf year ended 30th
the Company for the second

You are requested to take the same on records.

Thanking You,
Yours faithfutty,

GAURANG SHAH

Sr. G.lt. - Legal &


Company Secretary

Corporate ldentity Number - 124230M

1979P1C022059

You might also like